Peptides as an adjunctive treatment for acute myocardial infarction: Insights from the meta-analysis of 1,389 patients from 20 trials

International Heart Journal

Volumn 55, Issue 1, 2014, Pages 8-16

  Lyu, Ting ^a   Zhao, Yichao ^a   Zhang, Tuo ^a   Zhou, Wen ^a   Yang, Fan ^a   Ge, Heng ^a   Ding, Song ^a   Pu, Jun ^a   He, Ben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Left ventricular function

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ANIMAL; CLINICAL TRIAL (TOPIC); HEART INFARCTION; HUMAN; META ANALYSIS; REVIEW;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CLINICAL TRIALS AS TOPIC; HUMANS; MYOCARDIAL INFARCTION; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN;

EID: 84893634571     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.13-109     Document Type: Review

References (32)

1. Bettencourt P. Brain natriuretic peptide (nesiritide) in the treatment of heart failure. Cardiovasc Drug Rev 2002; 20: 27-36. (Review)
2. Saito Y. Roles of atrial natriuretic peptide and its therapeutic use. J Cardiol 2010; 56: 262-70. (Review)
3. Richards AM. Therapeutic potential of infused cardiac natriuretic peptides in myocardial infarction. Heart 2009; 95: 1299-300.
4. D'Souza SP, Yellon DM, Martin C, et al. B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol 2003; 284: H1592-600.
5. Ren B, Shen Y, Shao H, Qian J, Wu H, Jing H. Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats. Clin Chim Acta 2007; 377: 83-7.
6. Takata Y, Hirayama Y, Kiyomi S, et al. The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion. Cardiovasc Res 1996; 32: 286-93.
7. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
8. Cai WD, Li XL, Bi YP. Effectiveness and safety of recombinant human brain natriuretic peptide in aged patients with acute myocardial infarction complicated with heart failure. Acta Academiae Med Shandong 2010: 92-4.
9. Chen D, Huang L, Shang YJ. Effects of intravenous recombinant human brain natriuretic peptide after primary PCI on ventricular remodeling and ventricular function in patients with acte myocardial infarction. Jilin Med J 2011: 11-3.
10. Chen HH, Martin FL, Gibbons RJ, et al. Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study. Heart 2009; 95: 1315-9.
11. Ding ZJ. The short-term observation of rhBNP infusion in AMI patients receiving primary PCI [Master's paper]: Dalian Medical University; 2008.
12. Duan JB, Fu XH. The effect of intravenous infusion of rhBNP on left ventricular remodeling in AMI patients receiving XXX???? [Master's paper]: Hebei Medical University; 2007.
13. Hayashi M, Tsutamoto T, Wada A, et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 2001; 37: 1820-6.
14. Hillock RJ, Frampton CM, Yandle TG, Troughton RW, Lainchbury JG, Richards AM. B-type natriuretic peptide infusions in acute myocardial infarction. Heart 2008; 94: 617-22.
15. Kasama S, Toyama T, Hatori T, et al. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 2007; 49: 667-74.
16. Kitakaze M, Asakura M, Kim J, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 2007; 370: 1483-93.
17. Kuga H, Ogawa K, Oida A, et al. Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction. Circ J 2003; 67: 443-8.
18. Li HB, Xin JM, Zhao LC, Zhang Y, Sun WH, Zhu WB. Clinical evaluation of early low-dose nesiritide injection relieves left ventricular remodeling in acute myocardial infarction patients after PCI. Jilin Med J 2011: 690-2. (Chinese)
19. Liu CH, Lu JK, Li YH, Wang FZ. The function of BNP in acute myocardial infarction patients with heart failure. Heilongjiang Med Pharm 2010: 63-4. (Chinese)
20. Liu ND, Zhou X. Effect of rhBNP infusion in AMI patients complicated with acute heart failure. J Chinese Biochem 2011: 239-40.
21. Long SQ, Liu B, Zou GH, Chen YH. Effect of rhBNP therapy in AMI patients complicated with heart failure. J Chinese Med Drugs 2011: 81-2.
22. Ma YY, Han ZL, Wang SL, Wang DM. Clinical evaluation of rhBNP function in acute pump failure after STEMI. South China J Cardiovasc Dis 2009; Special Edition: 64.
23. Wang DY, Jin HG. Efficiency and safety evaluation of natriuretic peptide in treating acute myocardial infarction complicated with heart failure. J Shanghai Yixue 2008: 411-3.
24. Xue L, Fu XH, Wu WL, et al. rhBNP infusion on ventricular remodeling and contraction synchronism in AMI patients after PCI. J Chinese Circulation 2009: 170-3.
25. Zhang J, Fu XH, Jia XW. Efficacy and safety of recombinant human B-type natriuretic peptide on acute systolic heart failure patients with acute anterior myocardial infarction. China J Gereol 2010; 30: 438-41.
26. Zhao Q, Wu TG, Lin Y, Li B, Luo JY, Wang LX. Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction. Heart and Vessels 2010; 25: 97-103.
27. Zou RX, Xu ZP, Ding ZJ. Clinical evaluation of using BNP to treat acute myocardial infarction patients with heart failure. Med Innovation Res 2007; 4: 114.
28. Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic pep tides in cardioprotection. Cardiovasc Res 2006; 69: 318-28. (Review)
29. Silver MA. The natriuretic peptide system: kidney and cardiovascular effects. Curr Opin Nephrol Hypertens 2006; 15: 14-21. (Review)
30. Woods RL. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Clin Exp Pharmacol Physiol 2004; 31: 791-4. (Review)
31. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005; 111: 1487-91.
32. O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32-43.